This is a preprint.
"The problem is not detection, it is treatment": Exploring Why Women Needing Pre-Cervical Cancer Care are Lost to Follow-Up at the Hospital in Iquitos, Peru
- PMID: 39711532
- PMCID: PMC11661300
- DOI: 10.21203/rs.3.rs-5059371/v1
"The problem is not detection, it is treatment": Exploring Why Women Needing Pre-Cervical Cancer Care are Lost to Follow-Up at the Hospital in Iquitos, Peru
Update in
-
"The problem is not detection, it is treatment": exploring why women needing pre-cervical cancer care are lost to follow-up at the hospital in Iquitos, Peru.BMC Health Serv Res. 2025 Apr 14;25(1):544. doi: 10.1186/s12913-025-12685-x. BMC Health Serv Res. 2025. PMID: 40229789 Free PMC article.
Abstract
Background: The objective of this study was to investigate the barriers to follow-up of women with cervical lesions suspicious of cancer who were ineligible for primary-level treatment and needed, but did not receive, hospital-level care in Loreto, Peru.
Methods: In-depth, semi-structured interviews were conducted with 18 HPV-positive women requiring hospital-level follow-up care for cervical lesions suspicious of cancer but for whom there was no documentation of completion of treatment. After thematically analyzing these patient interviews, interview findings were presented to seven doctors and five nurse-midwives at both the hospital and the primary levels for comments and suggestions regarding barriers to treatment. Finally, all findings were presented at a group model building workshop with 19 health authorities and professionals, where action items were discussed to elicit suggestions for systems-level changes.
Results: Interviewed patients and healthcare professionals expressed the need to improve communication between levels of care, as well as the need to implement a patient navigation program. Interviewees also discussed the barriers patients encountered in obtaining hospital-level follow-up that ultimately affected their continuum of care. Patient-identified barriers to hospital care were grouped into three main themes: (1) limited patient understanding of treatment steps, (2) the need for multiple trips to the hospital to obtain care, and (3) lack of provider follow-up, leading to their suggestion for (4) the need for patient navigators. The healthcare professionals concurred with the barriers identified by the patients, but further elucidated suggestions for change such as (1) prioritizing patients with a high risk of cancer when referring to the hospital, and (2) increasing communication between the different levels of care. The group model building workshop served as a space to discuss findings and action items that could potentially make these changes possible.
Conclusions: Despite an overall increase in follow-up for HPV-positive women since the implementation of the new HPV-based screen-and-treat program, women at high risk of developing cervical cancer are still being lost to follow-up after being referred to the hospital for care. The challenges faced by both providers and patients are complex and require systems-level improvements.
Keywords: HPV; Loss to follow-up; cervical cancer; hospital-level care.
Conflict of interest statement
Competing interests VPS, on behalf of the Proyecto Precancer, received discounted prices and/or donated supplies from Copan and Cepheid. The authors declare that they have no other competing interests.
Figures
Similar articles
-
"The problem is not detection, it is treatment": exploring why women needing pre-cervical cancer care are lost to follow-up at the hospital in Iquitos, Peru.BMC Health Serv Res. 2025 Apr 14;25(1):544. doi: 10.1186/s12913-025-12685-x. BMC Health Serv Res. 2025. PMID: 40229789 Free PMC article.
-
Challenges associated with follow-up care after implementation of an HPV screen-and-treat program with ablative therapy for cervical cancer prevention in Iquitos, Peru: a mixed methods study.Res Sq [Preprint]. 2023 Aug 23:rs.3.rs-3210614. doi: 10.21203/rs.3.rs-3210614/v1. Res Sq. 2023. Update in: BMC Public Health. 2024 Aug 6;24(1):2121. doi: 10.1186/s12889-024-19436-3. PMID: 37674724 Free PMC article. Updated. Preprint.
-
Challenges associated with follow-up care after implementation of an HPV screen-and-treat program with ablative therapy for cervical cancer prevention.BMC Public Health. 2024 Aug 6;24(1):2121. doi: 10.1186/s12889-024-19436-3. BMC Public Health. 2024. PMID: 39107728 Free PMC article.
-
"Easy women get it": Pre-existing stigma associated with HPV and cervical cancer in a low-resource setting prior to implementation of an HPV screen-and-treat program.Res Sq [Preprint]. 2023 Sep 11:rs.3.rs-3256535. doi: 10.21203/rs.3.rs-3256535/v1. Res Sq. 2023. Update in: BMC Public Health. 2023 Dec 2;23(1):2396. doi: 10.1186/s12889-023-17324-w. PMID: 37790338 Free PMC article. Updated. Preprint.
-
Conceptual framework on barriers and facilitators to implementing perinatal mental health care and treatment for women: the MATRIx evidence synthesis.Health Soc Care Deliv Res. 2024 Jan;12(2):1-187. doi: 10.3310/KQFE0107. Health Soc Care Deliv Res. 2024. PMID: 38317290
References
-
- WHO. Global strategy to accelerate the elimination of cervical cancer as a public health problem. WHO. https://iris.who.int/bitstream/handle/10665/336583/9789240014107-eng.pdf.... Published 2020. Accessed.
-
- Falcaro M, et al. The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: A register-based observational study. Lancet. 2021;398(10316):2084–92. - PubMed
-
- WHO. Cervical Cancer. WHO. Fact Sheets Web site. Accessed; 2024. https://www.who.int/news-room/fact-sheets/detail/cervical-cancer.
-
- Bewley S. HPV vaccination and cervical cancer screening. The Lancet. 2022;399(10339); 1939. - PubMed
-
- WHO. Screening programmes: A short guide. Increase effectiveness, maximize benefits and minimize harm. WHO. https://www.who.int/europe/publications/i/item/9789289054782. Published 2020. Accessed.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources